GW Pharma (GWPH) Reports Q4 Loss of $0.18, Beats on Revenues

GW Pharma (NASDAQ: GWPH) reported Q4 EPS of ($0.18), versus ($1.67) reported last year. Revenue for the quarter came in at $2.86 million versus the consensus estimate of $2.52 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Robinhood shares climb on summit momentum and analyst support
• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation